Markov P V, Lisunov I M, Arutyunov O R
Vishnevsky National Medical Research Center of Surgery, Moscow, Russia.
Khirurgiia (Mosk). 2024(8):64-68. doi: 10.17116/hirurgia202408164.
We demonstrate robot-assisted treatment of a patient with benign pancreatic insulinoma. A 31-year-old patient suffered from attacks of weakness, numbness of the fingertips and «turbidity of consciousness» for 2 years. These symptoms occurred on an empty stomach and regressed after eating. We found pancreatic insulinoma. The patient underwent robotic enucleation of pancreatic tumor. Surgery time was 145 min. Postoperative period proceeded without complications. Hyperglycemia up to 10.5 mmol/l on the first postoperative day was followed by normalization after 4 days. The patient was discharged in 6 days after surgery. Minimally invasive robotic enucleation of insulinoma minimizes surgical trauma and provides precise resection of tumor. The key aspect of safe enucleation is localization of tumor at a distance of at least 2 mm from the pancreatic duct.
我们展示了机器人辅助治疗良性胰腺胰岛素瘤患者的过程。一名31岁患者两年来一直遭受乏力、指尖麻木和“意识模糊”发作。这些症状在空腹时出现，进食后缓解。我们发现了胰腺胰岛素瘤。该患者接受了胰腺肿瘤的机器人摘除术。手术时间为145分钟。术后过程无并发症。术后第一天血糖高达10.5 mmol/l，4天后恢复正常。患者术后6天出院。胰岛素瘤的微创机器人摘除术可将手术创伤降至最低，并能精确切除肿瘤。安全摘除的关键在于肿瘤定位要距离胰管至少2毫米。
